Download PDF
Semin Neurol 2015; 35(04): 424-430
DOI: 10.1055/s-0035-1558972
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Diabetic Neuropathies

Aaron Izenberg
1   Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
,
Bruce A. Perkins
2   Division of Endocrinology and Metabolism, Department of Medicine, University of Toronto and Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Canada
,
Vera Bril
3   Division of Neurology, Department of Medicine, Toronto General Hospital, Toronto, Ontario, Canada
› Author Affiliations
Further Information

Publication History

Publication Date:
06 October 2015 (online)

   Permissions and Reprints

Abstract

Diabetes mellitus is a common condition and diabetics are prone to develop a spectrum of neuropathic complications ranging from symmetric and diffuse to asymmetric and focal neuropathies that may be associated with significant morbidity. Diabetic sensorimotor polyneuropathy is the most common of these complications, occurring in patients with type 1 and 2 diabetes mellitus, as well as in those with prediabetes and glucose intolerance. In this review, the authors discuss the wide variety of neuropathies that can present in the context of diabetes, including the clinical manifestations, diagnostic features, and approach to management.

Keywords

diabetes - diabetic neuropathy - neuropathy - polyneuropathy
 

  • References

  • 1 National Diabetes Statistics Report. 2014 . Available at: http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf . Accessed January 2, 2015
    PubMed
  • 2 Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27 (5) 1047-1053
    Google Scholar
  • 3 Pirart J. [Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (author's transl)]. Diabete Metab 1977; 3 (2) 97-107
    PubMedGoogle Scholar
  • 4 Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 2011; 34 (10) 2220-2224
    CrossrefPubMedGoogle Scholar
  • 5 Albers JW, Herman WH, Pop-Busui R, Martin CL, Cleary P, Waberski B ; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Intervention and Complications (EDIC) Research Group. Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?. Diabetes Care 2007; 30 (10) 2613-2618
    CrossrefPubMedGoogle Scholar
  • 6 Dyck PJ, Kratz KM, Karnes JL , et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43 (4) 817-824
    CrossrefPubMedGoogle Scholar
  • 7 Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333 (2) 89-94
    CrossrefPubMedGoogle Scholar
  • 8 Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001; 24 (2) 250-256
    CrossrefPubMedGoogle Scholar
  • 9 Perkins BA, Orszag A, Ngo M, Ng E, New P, Bril V. Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study. Diabetes Care 2010; 33 (7) 1549-1554
    CrossrefPubMedGoogle Scholar
  • 10 Dyck PJ, Albers JW, Andersen H , et al; Toronto Expert Panel on Diabetic Neuropathy. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev 2011; 27 (7) 620-628
    Google Scholar
  • 11 England JD, Gronseth GS, Franklin G , et al; American Academy of Neurology; American Association of Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2005; 64 (2) 199-207
    CrossrefPubMedGoogle Scholar
  • 12 Perkins BA, Bril V. Electrophysiologic testing in diabetic neuropathy. In: Zochodne DW, Malik RA, eds. Handbook of Clinical Neurology, Vol. 126 (3rd Series) Diabetes and the Nervous System. Amsterdam, The Netherlands: Elsevier BV; 2014: 235-248
    Google Scholar
  • 13 Perkins BA, Ngo M, Bril V. Symmetry of nerve conduction studies in different stages of diabetic polyneuropathy. Muscle Nerve 2002; 25 (2) 212-217
    CrossrefPubMedGoogle Scholar
  • 14 Weisman A, Bril V, Ngo M , et al. Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters. PLoS ONE 2013; 8 (3) e58783
    CrossrefPubMedGoogle Scholar
  • 15 Fagerberg SE, Petersen I, Steg G, Wilhelmsen L. Motor disturbances in diabetes mellitus: a clinical study using electromyography and conduction velocity determination. Acta Med Scand 1963; 174: 711-716
    PubMedGoogle Scholar
  • 16 Dunnigan SK, Ebadi H, Breiner A , et al. Conduction slowing in diabetic sensorimotor polyneuropathy. Diabetes Care 2013; 36 (11) 3684-3690
    CrossrefPubMedGoogle Scholar
  • 17 Dunnigan SK, Ebadi H, Breiner A , et al. Comparison of diabetes patients with “demyelinating” diabetic sensorimotor polyneuropathy to those diagnosed with CIDP. Brain Behav 2013; 3 (6) 656-663
    CrossrefPubMedGoogle Scholar
  • 18 Dunnigan SK, Ebadi H, Breiner A , et al. The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes—an observational study. PLoS ONE 2014; 9 (2) e89344
    CrossrefPubMedGoogle Scholar
  • 19 Bril V, Nyunt M, Ngo M. Limits of the sympathetic skin response in patients with diabetic polyneuropathy. Muscle Nerve 2000; 23 (9) 1427-1430
    CrossrefPubMedGoogle Scholar
  • 20 Lauria G, Hsieh ST, Johansson O , et al; European Federation of Neurological Societies; Peripheral Nerve Society. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2010; 17 (7) 903-912 , e44–e49
    CrossrefPubMedGoogle Scholar
  • 21 Ahmed A, Bril V, Orszag A , et al. Detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes: a concurrent validity study. Diabetes Care 2012; 35 (4) 821-828
    CrossrefPubMedGoogle Scholar
  • 22 Hertz P, Bril V, Orszag A , et al. Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet Med 2011; 28 (10) 1253-1260
    CrossrefPubMedGoogle Scholar
  • 23 Quattrini C, Tavakoli M, Jeziorska M , et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 2007; 56 (8) 2148-2154
    CrossrefPubMedGoogle Scholar
  • 24 Tavakoli M, Quattrini C, Abbott C , et al. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 2010; 33 (8) 1792-1797
    CrossrefPubMedGoogle Scholar
  • 25 Nabavi Nouri M, Ahmed A, Bril V , et al. Diabetic neuropathy and axon reflex-mediated neurogenic vasodilatation in type 1 diabetes. PLoS ONE 2012; 7 (4) e34807
    CrossrefPubMedGoogle Scholar
  • 26 England JD, Gronseth GS, Franklin G , et al; American Academy of Neurology. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 2009; 72 (2) 177-184
    CrossrefPubMedGoogle Scholar
  • 27 Martin CL, Albers JW, Pop-Busui R ; DCCT/EDIC Research Group. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 2014; 37 (1) 31-38
    CrossrefPubMedGoogle Scholar
  • 28 Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 2012; 6: CD007543
    PubMedGoogle Scholar
  • 29 Bril V, England J, Franklin GM , et al; American Academy of Neurology; American Association of Neuromuscular and Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Evidence-Based Guideline: Treatment of Painful Diabetic Neuropathy: Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 2011; 76 (20) 1758-1765
    CrossrefPubMedGoogle Scholar
  • 30 Ametov AS, Barinov A, Dyck PJ , et al; SYDNEY Trial Study Group. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003; 26 (3) 770-776
    CrossrefPubMedGoogle Scholar
  • 31 Ziegler D, Ametov A, Barinov A , et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29 (11) 2365-2370
    CrossrefPubMedGoogle Scholar
  • 32 Wang H, Romano G, Frustaci ME , et al. Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial. Neurology 2014; 83 (7) 628-637
    CrossrefPubMedGoogle Scholar
  • 33 The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991; 151 (11) 2225-2229
    CrossrefPubMedGoogle Scholar
  • 34 Barbano RL, Herrmann DN, Hart-Gouleau S, Pennella-Vaughan J, Lodewick PA, Dworkin RH. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol 2004; 61 (6) 914-918
    CrossrefPubMedGoogle Scholar
  • 35 Ko SH, Park SA, Cho JH , et al. Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes: a 7-year follow-up study. Diabetes Care 2008; 31 (9) 1832-1836
    CrossrefPubMedGoogle Scholar
  • 36 Spallone V, Ziegler D, Freeman R , et al; Toronto Consensus Panel on Diabetic Neuropathy. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011; 27 (7) 639-653
    CrossrefPubMedGoogle Scholar
  • 37 Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003; 26 (6) 1895-1901
    CrossrefPubMedGoogle Scholar
  • 38 McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia 1980; 18 (4) 279-283
    PubMedGoogle Scholar
  • 39 Soliven B, Maselli R, Jaspan J , et al. Sympathetic skin response in diabetic neuropathy. Muscle Nerve 1987; 10 (8) 711-716
    CrossrefPubMedGoogle Scholar
  • 40 The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 1998; 41 (4) 416-423
    CrossrefPubMedGoogle Scholar
  • 41 Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA ; Midodrine Study Group. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. JAMA 1997; 277 (13) 1046-1051
    CrossrefPubMedGoogle Scholar
  • 42 Campbell IW, Ewing DJ, Clarke BF. Therapeutic experience with fludrocortisone in diabetic postural hypotension. BMJ 1976; 1 (6014) 872-874
    CrossrefPubMedGoogle Scholar
  • 43 Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain 2015; 138 (Pt 1): 43-52
    CrossrefPubMedGoogle Scholar
  • 44 Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol 2010; 67 (4) 534-541
    CrossrefPubMedGoogle Scholar
  • 45 Grewal J, Bril V, Lewis GF, Perkins BA. Objective evidence for the reversibility of nerve injury in diabetic neuropathic cachexia. Diabetes Care 2006; 29 (2) 473-474
    CrossrefPubMedGoogle Scholar
  • 46 Barohn RJ, Sahenk Z, Warmolts JR, Mendell JR. The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later. Arch Neurol 1991; 48 (11) 1130-1135
    CrossrefPubMedGoogle Scholar
  • 47 Dyck PJ, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999; 53 (9) 2113-2121
    CrossrefPubMedGoogle Scholar
  • 48 Dyck PJ, Windebank AJ. Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 2002; 25 (4) 477-491
    CrossrefPubMedGoogle Scholar
  • 49 Massie R, Mauermann ML, Staff NP , et al. Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. Brain 2012; 135 (Pt 10): 3074-3088
    CrossrefPubMedGoogle Scholar
  • 50 Kikta DG, Breuer AC, Wilbourn AJ. Thoracic root pain in diabetes: the spectrum of clinical and electromyographic findings. Ann Neurol 1982; 11 (1) 80-85
    CrossrefPubMedGoogle Scholar
  • 51 Pascoe MK, Low PA, Windebank AJ, Litchy WJ. Subacute diabetic proximal neuropathy. Mayo Clin Proc 1997; 72 (12) 1123-1132
    CrossrefPubMedGoogle Scholar
  • 52 Tamburin S, Zanette G. Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy. Pain Med 2009; 10 (8) 1476-1480
    CrossrefPubMedGoogle Scholar
  • 53 Kilfoyle D, Kelkar P, Parry GJ. Pulsed methylprednisolone is a safe and effective treatment for diabetic amyotrophy. J Clin Neuromuscul Dis 2003; 4 (4) 168-170
    CrossrefPubMedGoogle Scholar
  • 54 Chan YC, Lo YL, Chan ES. Immunotherapy for diabetic amyotrophy. Cochrane Database Syst Rev 2012; 6: CD006521
    PubMedGoogle Scholar
  • 55 Dyck PJ, O'Brien P, Bosch EP , et al. The multi-centre double-blind controlled trial of IV methylprednisolone in diabetic lumbosacral radiculoplexus neuropathy. Neurology 2006; 66 (Suppl. 02) A191
    PubMedGoogle Scholar
  • 56 Said G, Goulon-Goeau C, Lacroix C, Moulonguet A. Nerve biopsy findings in different patterns of proximal diabetic neuropathy. Ann Neurol 1994; 35 (5) 559-569
    CrossrefPubMedGoogle Scholar
  • 57 Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 2002; 25 (3) 565-569
    CrossrefPubMedGoogle Scholar
  • 58 Gazioglu S, Boz C, Cakmak VA. Electrodiagnosis of carpal tunnel syndrome in patients with diabetic polyneuropathy. Clin Neurophysiol 2011; 122 (7) 1463-1469
    CrossrefPubMedGoogle Scholar